Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Dextromoramide 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dextropropoxyphene hydrochloride 65 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dihydrocodeine 30 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dihydrocodeine tartrate 10mg/5mL elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dihydrocodeine tartrate 50mg/1mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dihydrocodeine tartrate 60mg m/r tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dihydrocodeine tartrate 90mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dihydrocodeine tartrate 120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dihydrocodeine 40 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levacetylmethadol hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing methadone analog (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Opiate agonist (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextropropoxyphene napsylate 50 mg and paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextropropoxyphene napsylate 100 mg and paracetamol 650 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Remifentanil (substance) |
Is a |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dipipanone |
Is a |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methadone |
Is a |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alfentanil (substance) |
Is a |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oral fluid opiate level (procedure) |
Component |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Urine methadone metabolite level |
Component |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Meptazinol |
Is a |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Squill opiate |
Is a |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Opium alkaloid (substance) |
Is a |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Opioid intoxication delirium |
Causative agent (attribute) |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Harmful pattern of use of opioid (disorder) |
Causative agent (attribute) |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dihydrocodeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Opiates |
Component |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Opioid-induced sexual dysfunction |
Causative agent (attribute) |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Quantitative measurement of opiate agonist |
Component |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Opioid intoxication |
Causative agent (attribute) |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Opioid withdrawal |
Causative agent (attribute) |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextromoramide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing opioid receptor agonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing aspirin and caffeine and propoxyphene hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing paracetamol and propoxyphene napsylate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opiate agonist (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|